APA (7th ed.) Citation

Munshi, N. C., Larry D. Anderson, J., Shah, N., Madduri, D., Berdeja, J., Lonial, S., . . . San-Miguel, J. (2021). Idecabtagene vicleucel in relapsed and refractory multiple myeloma. The New England journal of medicine, 384, . https://doi.org/10.1056/NEJMoa2024850

Chicago Style (17th ed.) Citation

Munshi, Nikhil C., et al. "Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma." The New England Journal of Medicine 384 (2021). https://doi.org/10.1056/NEJMoa2024850.

MLA (9th ed.) Citation

Munshi, Nikhil C., et al. "Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma." The New England Journal of Medicine, vol. 384, 2021, https://doi.org/10.1056/NEJMoa2024850.